Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
Chunmei Bai, Yi Zheng, Meili Sun, Jieer Ying, Fuxiang Zhou, Yiyi Yu, Ligang Xing, Yanqiao Zhang, Jinhua Wen, Heshui Wu, Xiuli Yang, Lixin Wan, Shiwei Guo, Rusen Zhao, Zhizhen Zhu, Wei Shen, Qi Wang, Shanzhi Gu, Hao Wu, Weichang Chen, Jin Xia, Jun Zhao, Xiaofang Dong, Wenhui Lou, Kuirong Jiang, Zhiye Zhang, Xiaobing Chen, Deliang Fu, Youshan Chen, Baoqing Wang, Jiaxin Liu, Yuan Ji, Shijie Yuan, Yuan Li, Zhihua Gong, Fei Da, Xia Qin, Crystal Qin, Jin Li
Topics & Concepts
Clinical trialMedicineOncologyPhases of clinical researchInternal medicineClaudinBayesian probabilityCancer researchMaximum tolerated dosePharmacologyTumor cellsSafety profileBarrier Structure and Function StudiesHER2/EGFR in Cancer ResearchPancreatic and Hepatic Oncology Research